Speaker's Bio

Günter Emons
 
Date of birth: January 28, 1954
 
Education and Academic
Titles: 
Approbation as physician 1979, Medical University of Lübeck
Promotion to Doctor medicinae 1982, Medical University of Lübeck
Habilitation for Biochemical Endocrinology 1986, Medical University of Lübeck
Specialist for Obstetrics and Gynecology 1988, Medical University, Lübeck
Associate Professor for Obstetrics and Gynecology
1991, Philipps University, Marburg
Specialist for Surgical Gynecology and Gynecologic Oncology 1996
Full Professor and Chairman  1998, University of Göttingen, Dept. of Obstetrics and Gynecology
Board Certificate: Gynecologic Oncology 2006
Board Certificate:  Medical Tumor Therapy in Gynecology 2006
 
Scientific activities:
basic science: 1979-1982: estrogen metabolism and estrogen-physiology
 1982-present: regulation of pituitary gonadotrophin
 secretion by estrogens, progestins, antiestrogens and
 antiprogestins; regulation of LHRH-receptor concentration
 and LHRH signal transduction
 1985-present: Expression of LHRH and its receptor in gynecologic
 cancers,LHRH signal transduction in cancers, pharmacological
 actions of LHRH agonists, LHRH antagonists and of cytotoxic LHRH
 analogs
 

clinical studies: 1986-1989: phase II trials with LHRH agonists in the treatment of hyperandrogenemic sterility, uterine fibroids and endometriosis;
 pharmacokinetics and bioavailability of LHRH analogs
 1987-1994: principal investigator of an international multicentre phase-
 III trial on the efficacy of LHRH agonist treatment in advanced ovarian
 cancer
 1992-1996: principal investigator of a German multicentre phase II
 trial on the efficacy of LHRH agonist treatment in advanced
 endometrial cancer
 1997-2000: principal investigator in a phase I/II trial on the efficacy of LHRH antagonist treatment in advanced ovarian cancer
 2001-present: principal investigator in a phase II trial on the efficacy of taxotere in advanced endometrial cancer
 2002-present: principal investigator in a phase I/II trial on the efficacy of faslodex in advanced endometrial cancer
 
Editor of scientific 
journals: June 1995-2001: co-editor of the European
 Journal of Endocrinology
August 1998-August 2004: editorial board member „Endocrine Related Cancer”
 Since May 1999: editorial board member „Onkologie“
 November 2000-2009 editorial board member “Trends in Endocrinology and Metabolism”